Postmenopausal osteoporosis: etiology, current diagnostic strategies, and nonprescription interventions.

نویسنده

  • Hosam K Kamel
چکیده

OBJECTIVE To describe the etiology, diagnosis, and nonprescription interventions for the prevention and treatment of postmenopausal osteoporosis. BACKGROUND Osteoporosis affects more than 20 million individuals in North America and is responsible for more than 1.5 million fractures in the United States. About 50% of white women in the United States will have an osteoporotic fracture during their lifetime. SUMMARY Postmenopausal osteoporosis is the result of estrogen deficiency, which results in up-regulation of several cytokines and excessive bone resorption. Various bone mineral density (BMD) testing methods are available, but the World Health Organization based the diagnosis of postmenopausal osteoporosis on the presence of a BMD T-score that is 2.5 standard deviations or greater below the mean for young women as assessed by dual-energy X-ray absorptiometry (DXA) at the hip, spine, and mid-radius. Ensuring adequate calcium and vitamin D intake is the cornerstone of any regimen aimed at preventing or treating postmenopausal osteoporosis. Other nonpharmacologic measures address modifiable risk factors for the disease and include exercise, smoking cessation, reducing consumption of caffeine and alcohol, and avoiding medications known to decrease bone mass. CONCLUSIONS Postmenopausal osteoporosis is the result of estrogen deficiency and excessive bone resorption. Ensuring intake combined with lifestyle changes to address modifiable risk factors for the disease may help in the prevention and treatment of this condition.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Performance of Postmenopausal Women in the Prevention of Osteoporosis Based on Health Belief Model

Introduction: Osteoporosis is one of the most important causes of illness and disability in postmenopausal females, characterized by a decrease in bone mass and increased fracture probability. Determination of the factors influencing the adoption of preventive behaviors for osteoporosis in postmenopausal females is necessary by using patterns such as the health belief model that identifies and ...

متن کامل

Similarities in Acquired Factors Related to Postmenopausal Osteoporosis and Sarcopenia

Postmenopausal population is at increased risk of musculoskeletal impairments. Sarcopenia and osteoporosis are associated with significant morbidity and social and health-care costs. These two conditions are uniquely linked with similarities in pathophysiology and diagnostic methods. Uniform diagnostic criteria for sarcopenia are still evolving. Postmenopausal sarcopenia and osteoporosis share ...

متن کامل

Update on bazedoxifene: A novel selective estrogen receptor modulator

In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients' unwillingness to take current therapies or inability to tolerate the therapies. For this reason, ongoing research continues to search for more effective and tolerable osteoporosis agents. Bazedoxifene is...

متن کامل

Design and Implementation of Educational Interventions to Empower Female Students to Prevent Osteoporosis

Introduction: Osteoporosis is a chronic disease which influences the life of people considerably, especially the women. Most women are not aware that osteoporosis is preventable. Although there is a higher risk of osteoporosis in postmenopausal women, but bone loss can begin at the age of 35. This research was conducted to design and implement educational interventions to empower female student...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of managed care pharmacy : JMCP

دوره 12 6 Suppl A  شماره 

صفحات  -

تاریخ انتشار 2006